It wasn’t until one of Benke’s friends confided that her own daughter had recently been diagnosed with Pediatric Growth ...
Sogroya is a long-acting form of somatropin. Somatropin is also called human growth hormone. Sogroya is made by attaching human growth hormone to a small protein that helps it stay in the body longer ...
Growth hormone helps children grow in height and supports healthy metabolism. When a child does not have enough of this hormone, their growth may be slow. This is sometimes called growth failure.
Human growth hormone (HGH) is a hormone that’s essential to our development. Most people produce enough HGH throughout their lifetime. But for those with a deficiency in growth hormone (or a few other ...
A Prescription Drug User Fee Act target date of July 27, 2025 has been set for the application. The Food and Drug Administration (FDA) has accepted for review the supplemental Biologics License ...
Please provide your email address to receive an email when new articles are posted on . Growth hormone deficiency, characterized by the inadequate secretion of GH from the anterior pituitary gland, is ...
Pfizer disclosed the regulatory action late Friday. FDA complete response letters are not public documents, and the company did not say what concerns or questions were raised by the agency about the ...
Deficiency of growth hormone and IGF-1 reduces cancer and kidney disease, but creates other problems
WINSTON-SALEM, N.C. – Deficiencies of growth hormone and similar compounds may reduce cancer and kidney disease late in life, but also may lead to cartilage degeneration and impaired memory and ...
Growth hormone (GH) therapy has evolved rapidly since the introduction of recombinant human GH (rhGH). The increase in the availability and safety of GH therapy has also increased the number of US ...
NEW YORK & MIAMI--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) and OPKO Health Inc. (NASDAQ: OPK) announced today that C0311002, a Phase 3, randomized, multicenter, open-label, crossover study evaluating ...
Ascendis Pharma A/SASND announced positive top-line data from its pivotal phase III study evaluating TransCon Growth Hormone (hGH) for treating growth hormone deficiency ("GHD") in children. Data from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results